Fundraising Fox

Greg Johnson

Investor

Founder and Managing Director at Prolog Ventures Β· Board director at Veran Medical

St Louis, Missouri, United States

Find your path to Greg

182 people in our graph share verified history with Greg β€” schools, employers, funds. One of them is your warm intro.

Michael OdaiunlockedGreg: together at University of Rochester
Γ—10Greg: together at University of Rochester
Greg: together at Monsanto

About

A Prolog co-founder and managing director with over 30 years in venture capital, Greg played an early-stage role in funding companies including Genelabs, Novellus, UroCor and Stereotaxis. He previously was a general partner at Gateway Associates and began his investing career in 1985 at Monsanto, where he oversaw its $80M venture portfolio. He holds a doctorate in physics from the University of Rochester and a bachelor's degree from MIT.

ContactΒ· self-published, not guessed

Invests in

Medical DevicesNew Materials

Board director at Veran Medical

Intro paths

β†’

In turn, Greg can intro founders to Veran Medical's investors below.

Experience

  1. Prolog VenturesManaging Directorcurrent2000 β€” present
  2. Veran Medical TechnologiesDirector2008 β€” 2018
  3. Akermin, Inc.Director2006 β€” 2016Greater St. Louis Area
  4. PixelEXX Systems, Inc.Director2010 β€” 2015Greater Chicago Area
  5. KereosDirector2005 β€” 2015
  6. IntelliCyt CorporationDirector2012 β€” 2014
  7. SingulexDirector2002 β€” 2012
  8. EraGen BiosciencesDirector2005 β€” 2011
  9. Gateway AssociatesGeneral Partner1987 β€” 2001Greater St. Louis Area
  10. Monsanto Venture CapitalVice President1985 β€” 1987St. Louis
  11. MonsantoDirector, Business Development1981 β€” 1985Brussels Area, Belgium

Skills & more

CommercializationTechnology TransferR&DVenture CapitalEnterprise ValuationStart-upsBusiness DevelopmentEntrepreneurshipLife SciencesBusiness StrategyBiotechnologyMergers & Acquisitions
+11 moreCorporate DevelopmentDue DiligenceStrategic PartnershipsProduct DevelopmentCross-functional Team LeadershipPrivate EquityMedical DevicesInvestmentsStrategic PlanningStrategyManagement

From Greg's professional profile.

Investments

Investor

GenelabsNovellusStereotaxisUroCor

Per the firm's website.

Colleagues at Prolog Ventures

Frequently asked questions

Who is Greg Johnson?
A Prolog co-founder and managing director with over 30 years in venture capital, Greg played an early-stage role in funding companies including Genelabs, Novellus, UroCor and Stereotaxis. He previously was a general partner at Gateway Associates and began his investing career in 1985 at Monsanto, where he oversaw its $80M venture portfolio. He holds a doctorate in physics from the University of Rochester and a bachelor's degree from MIT.
Where does Greg Johnson work?
Greg Johnson is Founder and Managing Director at Prolog Ventures and Board director at Veran Medical.
What does Greg Johnson invest in?
Greg Johnson invests in Medical Devices, New Materials.
What companies has Greg Johnson invested in?
Investments tracked here include Genelabs, Novellus, Stereotaxis, UroCor.
Where did Greg Johnson go to school?
Greg Johnson studied at Massachusetts Institute of Technology (S.B., Physics); University of Rochester (Ph.D., Physics).

Same school

Shared employers